Cited by 25Hydrogels: synthesis, properties, applicationsAdvanced Drug Delivery SystemsGlioma Diagnosis and Treatment

Intracranial In Situ Thermosensitive Hydrogel Delivery of Temozolomide Accomplished by PLGA–PEG–PLGA Triblock Copolymer Blending for GBM Treatment

Open access
Gu, Weinan, Fan, Ranran, Quan, Jingnan, Cheng, Yi, Wang, Shanshan, Zhang, Hui, Zheng, Aiping, Song, Shenghan·2022·Polymers

Abstract

Glioblastoma (GBM) recurrence after surgical excision has grown to be a formidable obstacle to conquer. In this research, biodegradable thermosensitive triblock copolymer, poly(D, L–lactic acid–co–glycolic acid)–b–poly(ethylene glycol)–b–poly(D, L–lactic acid–co–glycolic acid (PLGA–PEG–PLGA) was utilized as the drug delivery system, loading with micronized temozolomide(micro-TMZ) to form an in situ drug–gel depot inside the resection cavity. The rheology studies revealed the viscoelastic profile of hydrogel under various conditions. To examine the molecular characteristics that affect gelation temperature, 1H–NMR, inverse gated decoupling 13C–NMR, and GPC were utilized. Cryo-SEM and XRD were intended to disclose the appearance of the hydrogel and the micro-TMZ existence state. We worked out how to blend polymers to modify the gelation point (Tgel) and fit the correlation between Tgel and other dependent variables using linear regression. To simulate hydrogel dissolution in cerebrospinal fluid, a membraneless dissolution approach was used. In vitro, micro-TMZ@PLGA–PEG–PLGA hydrogel exhibited Korsmeyer–Peppas and zero–order release kinetics in response to varying drug loading, and in vivo, it suppressed GBM recurrence at an astoundingly high rate. Micro-TMZ@PLGA–PEG–PLGA demonstrates a safer and more effective form of chemotherapy than intraperitoneal TMZ injection, resulting in a spectacular survival rate (40%, n = 10) that is much more than intraperitoneal TMZ injection (22%, n = 9). By proving the viability and efficacy of micro-TMZ@PLGA–PEG–PLGA hydrogel, our research established a novel chemotherapeutic strategy for treating GBM recurrence.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/polym14163368

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PLGA can be formulated into injectable hydrogels, offering minimally invasive application and localized adhesion prevention, particularly in complex surgical sites.

    “Additionally, PLGA can be formulated into injectable hydrogels, which offer minimally invasive application and localized adhesion prevention, particularly in complex surgical sites [230].”

    From Biomaterials in Postoperative Adhesion Barriers and Uterine Tissue Engineering (2025) · cites this paper as [230]

    The Materials and Methods section (2.4) describes intracranial injection of a PLGA–PEG–PLGA hydrogel, supporting the injectable-hydrogel part of the claim. The paper studies local delivery for glioblastoma treatment, but the passages do not report adhesion prevention or establish a minimally invasive advantage in complex surgical sites. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 83

  1. [1]Al-Mousa A. Al-Dwairy S. Dajani N. Sami R. Shtaya A. Giant cell glioblastoma multiforme presents as acute pathological nontraumatic subdural haematoma Br. J. Neurosurg. 2020 10.1080/02688697.2020.1866747 33369511 · DOI
  2. [2]Ostrom Q.T. Patil N. Cioffi G. Waite K. Kruchko C. Barnholtz-Sloan J.S. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013–2017 Neuro Oncol. 2020 22 1 96 10.1093/neuonc/noaa200 33123732 PMC7596247 · DOI
  3. [3]Smith S.J. Tyler B.M. Gould T. Veal G.J. Gorelick N. Rowlinson J. Serra R. Ritchie A. Berry P. Otto A. Overall Survival in Malignant Glioma Is Significantly Prolonged by Neurosurgical Delivery of Etoposide and Temozolomide from a Thermo-Responsive Biodegradable Paste Clin. Cancer Res. 2019 25 5094 5106 10.1158/1078-0432.CCR-18-3850 31113843 · DOI
  4. [4]Vellimana A.K. Recinos V.R. Hwang L. Fowers K.D. Li K.W. Zhang Y. Okonma S. Eberhart C.G. Brem H. Tyler B.M. Combination of paclitaxel thermal gel depot with temozolomide and radiotherapy significantly prolongs survival in an experimental rodent glioma model J. Neurooncol. 2013 111 229 236 10.1007/s11060-012-1014-1 23224713 PMC4029109 · DOI
  5. [5]Zhao M. Bozzato E. Joudiou N. Ghiassinejad S. Danhier F. Gallez B. Preat V. Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection J. Control. Release 2019 309 72 81 10.1016/j.jconrel.2019.07.015 31306678 · DOI
  6. [6]Serris I. Serris P. Frey K.M. Cho H. Development of 3D-Printed Layered PLGA Films for Drug Delivery and Evaluation of Drug Release Behaviors AAPS Pharm. Sci. Tech. 2020 21 256 10.1208/s12249-020-01790-1 32888114 · DOI
  7. [7]Perry J. Chambers A. Spithoff K. Laperriere N. Gliadel wafers in the treatment of malignant glioma: A systematic review Curr. Oncol. 2007 14 189 194 10.3747/co.2007.147 17938702 PMC2002480 · DOI
  8. [8]Kim Y.Z. Kim C.Y. Lim J. Sung K.S. Lee J. Oh H.J. Kang S.G. Kang S.H. Kong D.S. Kim S.H. The Korean Society for Neuro-Oncology (KSNO) Guideline for Glioblastomas: Version 2018.01 Brain Tumor Res. Treat. 2019 7 1 9 10.14791/btrt.2019.7.e25 31062525 PMC6504754 · DOI
  9. [9]Ramalho M.J. Andrade S. Coelho M.A.N. Loureiro J.A. Pereira M.C. Biophysical interaction of temozolomide and its active metabolite with biomembrane models: The relevance of drug-membrane interaction for Glioblastoma Multiforme therapy Eur. J. Pharm. Biopharm. 2019 136 156 163 10.1016/j.ejpb.2019.01.015 30682492 · DOI
  10. [10]Masi B.C. Tyler B.M. Bow H. Wicks R.T. Xue Y. Brem H. Langer R. Cima M.J. Intracranial MEMS based temozolomide delivery in a 9L rat gliosarcoma model Biomaterials 2012 33 5768 5775 10.1016/j.biomaterials.2012.04.048 22591609 PMC4404638 · DOI
  11. [11]Tseng Y.Y. Kau Y.C. Liu S.J. Advanced interstitial chemotherapy for treating malignant glioma Expert Opin. Drug Deliv. 2016 13 1533 1544 10.1080/17425247.2016.1193153 27248137 · DOI
  12. [12]Wang P. Zhuo X. Chu W. Tang X. Exenatide-loaded microsphere/thermosensitive hydrogel long-acting delivery system with high drug bioactivity Int. J. Pharm. 2017 528 62 75 10.1016/j.ijpharm.2017.05.069 28579543 · DOI
  13. [13]Zhuang Y. Yang X. Li Y. Chen Y. Peng X. Yu L. Ding J. Sustained Release Strategy Designed for Lixisenatide Delivery to Synchronously Treat Diabetes and Associated Complications ACS Appl. Mater. Interfaces 2019 11 29604 29618 10.1021/acsami.9b10346 31361112 · DOI
  14. [14]Zhang L. Shen W. Luan J. Yang D. Wei G. Yu L. Lu W. Ding J. Sustained intravitreal delivery of dexamethasone using an injectable and biodegradable thermogel Acta Biomater. 2015 23 271 281 10.1016/j.actbio.2015.05.005 26004219 · DOI
  15. [15]Chen X. Zhang J. Wu K. Wu X. Tang J. Cui S. Cao D. Liu R. Peng C. Yu L. Visualizing the In Vivo Evolution of an Injectable and Thermosensitive Hydrogel Using Tri-Modal Bioimaging Small Methods 2020 4 2000310 10.1002/smtd.202000310 · DOI
  16. [16]Yang Z. Yu S. Li D. Gong Y. Zang J. Liu J. Chen X. The effect of PLGA-based hydrogel scaffold for improving the drug maximum-tolerated dose for in situ osteosarcoma treatment Colloids Surf. B Biointerfaces 2018 172 387 394 10.1016/j.colsurfb.2018.08.048 30193198 · DOI
  17. [17]Yang X. Chen X. Wang Y. Xu G. Yu L. Ding J. Sustained release of lipophilic gemcitabine from an injectable polymeric hydrogel for synergistically enhancing tumor chemoradiotherapy Chem. Eng. J. 2020 396 125320 10.1016/j.cej.2020.125320 · DOI
  18. [18]Wang M. Zhan J. Xu L. Wang Y. Lu D. Li Z. Li J. Luo F. Tan H. Synthesis and characterization of PLGA-PEG-PLGA based thermosensitive polyurethane micelles for potential drug delivery J. Biomater. Sci. Polym. Ed. 2021 32 613 634 10.1080/09205063.2020.1854413 33218294 · DOI
  19. [19]Wu X. Wang X. Chen X. Yang X. Ma Q. Xu G. Yu L. Ding J. Injectable and thermosensitive hydrogels mediating a universal macromolecular contrast agent with radiopacity for noninvasive imaging of deep tissues Bioact. Mater. 2021 6 4717 4728 10.1016/j.bioactmat.2021.05.013 34136722 PMC8165329 · DOI
  20. [20]Khaledi S. Jafari S. Hamidi S. Molavi O. Davaran S. Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-Fluorouracil and Chrysin J. Biomater. Sci. Polym. Ed. 2020 31 1107 1126 10.1080/09205063.2020.1743946 32249693 · DOI
  21. [21]Song Z. Feng R. Sun M. Guo C. Gao Y. Li L. Zhai G. Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: Preparation, pharmacokinetics and distribution in vivo J. Colloid Interface Sci. 2011 354 116 123 10.1016/j.jcis.2010.10.024 21044788 · DOI
  22. [22]Wu K. Chen X. Gu S. Cui S. Yang X. Yu L. Ding J. Decisive Influence of Hydrophobic Side Chains of Polyesters on Thermoinduced Gelation of Triblock Copolymer Aqueous Solutions Macromolecules 2021 54 7421 7433 10.1021/acs.macromol.1c00959 · DOI
  23. [23]Hoang Thi T.T. Sinh L.H. Huynh D.P. Nguyen D.H. Huynh C. Self-Assemblable Polymer Smart-Blocks for Temperature-Induced Injectable Hydrogel in Biomedical Applications Front. Chem. 2020 8 19 10.3389/fchem.2020.00019 32083052 PMC7005785 · DOI
  24. [24]Yu L. Zhang Z. Zhang H. Ding J. Mixing a sol and a precipitate of block copolymers with different block ratios leads to an injectable hydrogel Biomacromolecules 2009 10 1547 1553 10.1021/bm900145g 19385649 · DOI
  25. [25]Qu J.Z. Kao L.W. Smith J.E. Kuo A. Xue A. Iyer M.H. Essandoh M.K. Dalia A.A. Brain Protection in Aortic Arch Surgery: An Evolving Field J. Cardiothorac Vasc. Anesth. 2021 35 1176 1188 10.1053/j.jvca.2020.11.035 33309497 · DOI
  26. [26]Xie Y. Liu J. Cai S. Bao X. Li Q. Xu G. Setting Characteristics and High Compressive Strength of an Anti-washout, Injectable Calcium Phosphate Cement Combined with Thermosensitive Hydrogel Materials 2020 13 5779 10.3390/ma13245779 PMC7766756 33348902 · DOI
  27. [27]Wei W. Li H. Yin C. Tang F. Research progress in the application of in situ hydrogel system in tumor treatment Drug Deliv. 2020 27 460 468 10.1080/10717544.2020.1739171 32166987 PMC7144265 · DOI
  28. [28]Liang P. Wang G. Liu X. Wang Z. Wang J. Gao W. Spatiotemporal combination of thermosensitive polypeptide fused interferon and temozolomide for post-surgical glioblastoma immunochemotherapy Biomaterials 2021 264 120447 10.1016/j.biomaterials.2020.120447 33069137 · DOI
  29. [29]Mirabdaly S. Elieh D. Shakiba Y. Moini A. Kiani A. Effects of temozolomide on U87MG glioblastoma cell expression of CXCR4, MMP2, MMP9, VEGF, anti-proliferatory cytotoxic and apoptotic properties Mol. Biol. Rep. 2020 47 1187 1197 10.1007/s11033-019-05219-2 31897867 · DOI
  30. [30]Sidell D. Ward J.A. Pordal A. Quimby C. Nassar M. Choo D.I. Combination therapies using an intratympanic polymer gel delivery system in the guinea pig animal model: A safety study Int. J. Pediatr. Otorhinolaryngol. 2016 84 132 136 10.1016/j.ijporl.2016.03.002 27063768 · DOI
  31. [31]Cuming R.S. Abarca E.M. Duran S. Wooldridge A.A. Stewart A.J. Ravis W. Babu R.J. Lin Y.J. Hathcock T. Development of a Sustained-Release Voriconazole-Containing Thermogel for Subconjunctival Injection in Horses Invest. Ophthalmol. Vis. Sci. 2017 58 2746 2754 10.1167/iovs.16-20899 28549089 · DOI
  32. [32]Mora-Pereira M. Abarca E.M. Duran S. Ravis W. Mcmullen R.J. Jr. Fischer B.M. Lee Y.P. Wooldridge A A. Sustained-release voriconazole-thermogel for subconjunctival injection in horses: Ocular toxicity and in-vivo studies BMC Vet. Res. 2020 16 115 10.1186/s12917-020-02331-5 32295599 PMC7160932 · DOI
  33. [33]Ata F. Akkam V.S.F. Gaber M. Omar N.E. Madani A. Mah A.H. Aldardouri M.M. Amer A. Kohla S. Zar G.A.R. Fatal temozolomide induced aplastic anemia in a female with Glioblastoma multiforme: A case report and literature review Clin. Case Rep. 2021 9 1641 1646 10.1002/ccr3.3860 33768906 PMC7981661 · DOI
  34. [34]Patel N. Ji N. Wang Y. Li X. Langley N. Tan C. Subcutaneous Delivery of Albumin: Impact of Thermosensitive Hydrogels AAPS Pharm. Sci. Tech. 2021 22 120 10.1208/s12249-021-01982-3 33782742 · DOI
  35. [35]Afzalipour R. Khoei S. Khoee S. Shirvalilou S. Raoufi N.J. Motevalian M. Karimi M.Y. Thermosensitive magnetic nanoparticles exposed to alternating magnetic field and heat-mediated chemotherapy for an effective dual therapy in rat glioma model Nanomedicine 2021 31 102319 10.1016/j.nano.2020.102319 33068745 · DOI
  36. [36]Yang Z. Liu J. Lu Y. Doxorubicin and CDCUR inclusion complex coloaded in thermosensitive hydrogel PLGAPEGPLGA localized administration for osteosarcoma Int. J. Oncol. 2020 57 433 444 10.3892/ijo.2020.5067 32468050 PMC7307595 · DOI
  37. [37]Chen Y. Li Y. Shen W. Li K. Yu L. Chen Q. Ding J. Controlled release of liraglutide using thermogelling polymers in treatment of diabetes Sci. Rep. 2016 6 31593 10.1038/srep31593 27531588 PMC4987673 · DOI
  38. [38]Shi J. Yu L. Ding J. PEG-based thermosensitive and biodegradable hydrogels Acta Biomater. 2021 128 42 59 10.1016/j.actbio.2021.04.009 33857694 · DOI
  39. [39]Chen X. Wang M. Yang X. Wang Y. Yu L. Sun J. Ding J. Injectable hydrogels for the sustained delivery of a HER2-targeted antibody for preventing local relapse of HER2+ breast cancer after breast-conserving surgery Theranostics 2019 9 6080 6098 10.7150/thno.36514 31534538 PMC6735507 · DOI
  40. [40]Xu W.K. Tang J.-Y. Yuan Z. Cai C.-Y. Chen X.-B. Cui S.-Q. Liu P. Yu L. Cai K.-Y. Ding J.-D. Accelerated Cutaneous Wound Healing Using an Injectable Teicoplanin-loaded PLGA-PEG-PLGA Thermogel Dressing Chin. J. Polym. Sci. 2019 37 548 559 10.1007/s10118-019-2212-5 · DOI
  41. [41]Giraudeau P. Baguet E. Improvement of the inverse-gated-decoupling sequence for a faster quantitative analysis of various samples by 13C NMR spectroscopy J. Magn. Reson. 2006 180 110 117 10.1016/j.jmr.2006.01.015 16488168 · DOI
  42. [42]Giraudeau P. Wang J.L. Baguet É. Improvement of the inverse-gated-decoupling sequence for a faster quantitative analysis by 13C NMR Comptes Rendus Chim. 2006 9 525 529 10.1016/j.crci.2005.06.030 16488168 · DOI
  43. [43]Yan X. Fang W.W. Xue J. Sun T.C. Dong L. Zha Z. Qian H. Song Y.H. Zhang M. Gong X. Thermoresponsive in Situ Forming Hydrogel with Sol-Gel Irreversibility for Effective Methicillin-Resistant Staphylococcus aureus Infected Wound Healing ACS Nano 2019 13 10074 10084 10.1021/acsnano.9b02845 31430428 · DOI
  44. [44]Zhou N. Hu K. Guo Z. Zhang Q. Chen J. Zhang T. Gu N. Thermo-Sensitive PLGA-PEG-PLGA Tri-Block Copolymer Hydrogel as Three-Dimensional Cell Culture Matrix for Ovarian Cancer Cells J. Nanosci. Nanotechnol. 2018 18 5252 5255 10.1166/jnn.2018.15372 29458574 · DOI
  45. [45]Vojtova L. Michlovska L. Valova K. Zboncak M. Trunec M. Castkova K. Krticka M. Pavlinakova V. Polacek P. Dzurov M. The Effect of the Thermosensitive Biodegradable PLGA(-)PEG(-)PLGA Copolymer on the Rheological, Structural and Mechanical Properties of Thixotropic Self-Hardening Tricalcium Phosphate Cement Int. J. Mol. Sci. 2019 20 391 10.3390/ijms20020391 PMC6359562 30658476 · DOI
  46. [46]Liu D. Wu Q. Zhu Y. Liu Y. Xie X. Li S. Lin H. Chen W. Zhu F. Co-delivery of metformin and levofloxacin hydrochloride using biodegradable thermosensitive hydrogel for the treatment of corneal neovascularization Drug Deliv. 2019 26 522 531 10.1080/10717544.2019.1609623 31090470 PMC6534255 · DOI
  47. [47]Chan P.S. Xian J.W. Li Q. Chan C.W. Leung S.S.Y. To K.K.W. Biodegradable Thermosensitive PLGA-PEG-PLGA Polymer for Non-irritating and Sustained Ophthalmic Drug Delivery AAPS J. 2019 21 59 10.1208/s12248-019-0326-x 31020458 · DOI
  48. [48]Liu Y. Chen X. Li S. Guo Q. Xie J. Yu L. Xu X. Ding C. Li J. Ding J. Calcitonin-Loaded Thermosensitive Hydrogel for Long-Term Antiosteopenia Therapy ACS Appl. Mater. Interfaces 2017 9 23428 23440 10.1021/acsami.7b05740 28640588 · DOI
  49. [49]Huang C. Fu C. Qi Z.P. Guo W.L. You D. Li R. Zhu Z. Localised delivery of quercetin by thermo-sensitive PLGA-PEG-PLGA hydrogels for the treatment of brachial plexus avulsion Artif. Cells Nanomed. Biotechnol. 2020 48 1010 1021 10.1080/21691401.2020.1770265 32608269 · DOI
  50. [50]Wang S.J. Qin J.Z. Zhang T.E. Xia C. Intra-articular Injection of Kartogenin-Incorporated Thermogel Enhancing Osteoarthritis Treatment Front. Chem. 2019 7 677 10.3389/fchem.2019.00677 31681730 PMC6813204 · DOI
  51. [51]Yang X. Shah S.J. Wang Z. Agrahari V. Pal D. Mitra A.K. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir Drug Deliv. 2016 23 2399 2409 10.3109/10717544.2014.996833 25564964 · DOI
  52. [52]Yu L. Chang G.T. Zhang H. Ding J.D. Injectable block copolymer hydrogels for sustained release of a PEGylated drug Int. J. Pharm. 2008 348 95 106 10.1016/j.ijpharm.2007.07.026 17825508 · DOI
  53. [53]Yap L.S. Yang M.C. Thermo-reversible injectable hydrogel composing of pluronic F127 and carboxymethyl hexanoyl chitosan for cell-encapsulation Colloids Surf. B Biointerfaces 2020 185 110606 10.1016/j.colsurfb.2019.110606 31698265 · DOI
  54. [54]Mellati A. Valizadeh K.M. Dai S. Bi J. Jin B. Zhang H. Influence of polymer molecular weight on the in vitro cytotoxicity of poly (N-isopropylacrylamide) Mater. Sci. Eng. C Mater. Biol. Appl. 2016 59 509 513 10.1016/j.msec.2015.10.043 26652402 · DOI
  55. [55]Yu X. Sun L. Tan L. Wang M. Ren X. Pi J. Jiang M. Li N. Preparation and Characterization of PLGA-PEG-PLGA Nanoparticles Containing Salidroside and Tamoxifen for Breast Cancer Therapy AAPS Pharm. Sci. Tech. 2020 21 85 10.1208/s12249-019-1523-8 31997020 · DOI
  56. [56]Chan P.S. Li Q. Zhang B. To K.K.W. Leung S.S.Y. In vivo biocompatibility and efficacy of dexamethasone-loaded PLGA-PEG-PLGA thermogel in an alkali-burn induced corneal neovascularization disease model Eur. J. Pharm. Biopharm. 2020 155 190 198 10.1016/j.ejpb.2020.08.022 32871195 · DOI
  57. [57]Yogev S. Shabtay-Orbach A. Nyska A. Mizrahi B. Local Toxicity of Topically Administrated Thermoresponsive Systems: In Vitro Studies with In Vivo Correlation Toxicol. Pathol. 2019 47 426 432 10.1177/0192623318810199 30407122 · DOI
  58. [58]Lin W. Xu T. Wang Z. Chen J. Sustained intrathecal delivery of amphotericin B using an injectable and biodegradable thermogel Drug Deliv. 2021 28 499 509 10.1080/10717544.2021.1892242 33657949 PMC7935127 · DOI
  59. [59]Liu P. Wang B. Qiao W. Li J. Novel thermosensitive nano-micelles from triblock copolymer for drug delivery J. Biomed. Nanotechnol. 2009 5 310 313 10.1166/jbn.2009.1036 20055013 · DOI
  60. [60]Dutta K. Das R. Ling J. Monibas R.M. Carballo-Jane E. Kekec A. Feng D.D. Lin S. Mu J. Saklatvala R. In Situ Forming Injectable Thermoresponsive Hydrogels for Controlled Delivery of Biomacromolecules ACS Omega 2020 5 17531 17542 10.1021/acsomega.0c02009 32715238 PMC7379096 · DOI
  61. [61]Zhang Y. Zhang J. Xu W. Xiao G. Ding J. Chen X. Tumor microenvironment-labile polymer-doxorubicin conjugate thermogel combined with docetaxel for in situ synergistic chemotherapy of hepatoma Acta Biomater. 2018 77 63 73 10.1016/j.actbio.2018.07.021 30006312 · DOI
  62. [62]Sulaiman T.N.S. Larasati D. Nugroho A.K. Choiri S. Assessment of the Effect of PLGA Co-polymers and PEG on the Formation and Characteristics of PLGA-PEG-PLGA Co-block Polymer Using Statistical Approach Adv. Pharm. Bull. 2019 9 382 392 10.15171/apb.2019.045 31592431 PMC6773940 · DOI
  63. [63]Yan Q. Xiao L.Q. Tan L. Sun W. Wu T. Chen L.W. Mei Y. Shi B. Controlled release of simvastatin-loaded thermo-sensitive PLGA-PEG-PLGA hydrogel for bone tissue regeneration: In vitro and in vivo characteristics J. Biomed. Mater. Res. A 2015 103 3580 3589 10.1002/jbm.a.35499 25969423 · DOI
  64. [64]Lopez-Cano J.J. Sigen A. Andres-Guerrero V. Tai H. Bravo-Osuna I. Molina-Martinez I.T. Wang W. Herrero-Vanrell R. Thermo-Responsive PLGA-PEG-PLGA Hydrogels as Novel Injectable Platforms for Neuroprotective Combined Therapies in the Treatment of Retinal Degenerative Diseases Pharmaceutics 2021 13 234 10.3390/pharmaceutics13020234 33562265 PMC7915560 · DOI
  65. [65]Zhen W. Zhu Y. Wang W. Hou Z. Synthesis and Properties of Amphipathic Poly(D,L-lactide-co-glycolide)-polyethylene glycol-poly(D,L-lactide-co-glycolide) Triblock Copolymers Aust. J. Chem. 2015 68 1593 1598 10.1071/CH15094 · DOI
  66. [66]Steinman N.Y. Haim Z.M. Goldstein I.A. Goldberg A.H. Haber T. Berlin J.M. Domb A.J. Effect of PLGA block molecular weight on gelling temperature of PLGA-PEG-PLGA thermoresponsive copolymers J. Polym. Sci. Part. A Polym. Chem. 2018 57 35 39 10.1002/pola.29275 · DOI
  67. [67]Wang P. Chu W. Zhuo X. Zhang Y. Gou J. Ren T. He H. Yin T. Tang X. Modified PLGA-PEG-PLGA thermosensitive hydrogels with suitable thermosensitivity and properties for use in a drug delivery system J. Mater. Chem. B 2017 5 1551 1565 10.1039/C6TB02158A 32263928 · DOI
  68. [68]Chen L. Ci T. Yu L. Ding J. Effects of Molecular Weight and Its Distribution of PEG Block on Micellization and Thermogellability of PLGA–PEG–PLGA Copolymer Aqueous Solutions Macromolecules 2015 48 3662 3671 10.1021/acs.macromol.5b00168 · DOI
  69. [69]Qiao M. Chen D. Hao T. Zhao X. Hu H. Ma X. Effect of bee venom peptide-copolymer interactions on thermosensitive hydrogel delivery systems Int. J. Pharm. 2007 345 116 124 10.1016/j.ijpharm.2007.05.056 17629639 · DOI
  70. [70]Newlands E.S. Stevens M.F. Wedge S.R. Wheelhouse R.T. Brock C. Temozolomide: A review of its discovery, chemical properties, pre-clinical development and clinical trials Cancer Treat. Rev. 1997 23 35 61 10.1016/S0305-7372(97)90019-0 9189180 · DOI
  71. [71]Ahad A. Shakeel F. Raish M. Ahmad A. Bin Jardan Y.A. Al-Jenoobi F.I. Al-Mohizea A.M. Thermodynamic Solubility Profile of Temozolomide in Different Commonly Used Pharmaceutical Solvents Molecules 2022 27 1437 10.3390/molecules27041437 35209225 PMC8879539 · DOI
  72. [72]Kim H.K. Lin C.C. Parker D. Veals J. Lim J. Likhari P. Statkevich P. Marco A. Nomeir A.A. High-performance liquid chromatographic determination and stability of 5-(3-methyltriazen-1-yl)-imidazo-4-carboximide, the biologically active product of the antitumor agent temozolomide, in human plasma J. Chromatogr. B Biomed. Sci. Appl. 1997 703 225 233 10.1016/S0378-4347(97)00431-3 9448080 · DOI
  73. [73]Andrasi M. Bustos R. Gaspar A. Gomez F.A. Klekner A. Analysis and stability study of temozolomide using capillary electrophoresis J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2010 878 1801 1808 10.1016/j.jchromb.2010.05.008 20627825 · DOI
  74. [74]Uebbing L. Klumpp L. Webster G.K. Lobenberg R. Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models Drug Des. Devel. 2017 11 1163 1174 10.2147/DDDT.S131213 PMC5395276 28442890 · DOI
  75. [75]Gao Y. Ji H. Peng L. Gao X. Jiang S. Development of PLGA-PEG-PLGA Hydrogel Delivery System for Enhanced Immunoreaction and Efficacy of Newcastle Disease Virus DNA Vaccine Molecules 2020 25 2505 10.3390/molecules25112505 PMC7321080 32481518 · DOI
  76. [76]Graham-Gurysh E.G. Murthy A.B. Moore K.M. Hingtgen S.D. Bachelder E.M. Ainslie K.M. Synergistic drug combinations for a precision medicine approach to interstitial glioblastoma therapy J. Control. Release 2020 323 282 292 10.1016/j.jconrel.2020.04.028 32335153 PMC7453575 · DOI
  77. [77]Sun J. Walker J. Beck-Broichsitter M. Schwendeman S.P. Characterization of commercial PLGAs by NMR spectroscopy Drug Deliv. Transl. Res. 2021 12 720 729 10.1007/s13346-021-01023-3 34415565 · DOI
  78. [78]Cespi M. Bonacucina G. Tiboni M. Casettari L. Cambriani A. Fini F. Perinelli D.R. Palmieri G.F. Insights in the rheological properties of PLGA-PEG-PLGA aqueous dispersions: Structural properties and temperature-dependent behaviour Polymer 2021 213 123216 10.1016/j.polymer.2020.123216 · DOI
  79. [79]Shapira-Furman T. Serra R. Gorelick N. Doglioli M. Tagliaferri V. Cecia A. Peters M. Kumar A. Rottenberg Y. Langer R. Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer J. Control. Release 2019 295 93 101 10.1016/j.jconrel.2018.12.048 30605703 · DOI
  80. [80]Zhao Z. Shen J. Zhang L. Wang L. Xu H. Han Y. Jia J. Lu Y. Yu R. Liu H. Injectable postoperative enzyme-responsive hydrogels for reversing temozolomide resistance and reducing local recurrence after glioma operation Biomater. Sci. 2020 8 5306 5316 10.1039/D0BM00338G 32573615 · DOI
  81. [81]Ngo M.T. Karvelis E. Harley B.A.C. Multidimensional hydrogel models reveal endothelial network angiocrine signals increase glioblastoma cell number, invasion, and temozolomide resistance Integr. Biol. 2020 12 139 149 10.1093/intbio/zyaa010 32507878 PMC7296128 · DOI
  82. [82]Garrett M.C. O’shea T.M. Wollenberg A.L. Bernstein A.M. Hung D. Staarman B. Soto H. Deming T.J. Sofroniew M.V. Kornblum H.I. Injectable diblock copolypeptide hydrogel provides platform to deliver effective concentrations of paclitaxel to an intracranial xenograft model of glioblastoma PLoS ONE 2020 15 e0219632 10.1371/journal.pone.0219632 32706829 PMC7380637 · DOI
  83. [83]Ortiz R. Perazzoli G. Cabeza L. Jimenez-Luna C. Luque R. Prados J. Melguizo C. Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications Curr. Neuropharmacol. 2021 19 513 537 10.2174/1570159X18666200626204005 32589560 PMC8206461 · DOI

Cited by

Sorted by citations

Authors
Gu, W., Fan, R., Quan, J., Cheng, Y., Wang, S., Zhang, H., Zheng, A., & Song, S.
Affiliations
  • Xuzhou Medical College (CN)
  • State Key Laboratory of Toxicology and Medical Countermeasures, Institute of Pharmacology and Toxicology, Beijing 100850, China
  • Capital Medical University (CN)
Corresponding author
  • Zheng, Aiping
  • Song, Shenghan
Venue
Polymers
Publisher
MDPI AG
Published
2022-08-18
Volume
14
Issue
16
Pages
3368
ISSN
2073-4360 (ISSN-L)
OpenAlex
W4293514197
Cited by
25
References
0
Citations by year
2026: 7 · 2025: 6 · 2024: 6 · 2023: 5 · 2022: 1
FWCI
1.45
Type
journal article
Language
en
Open access
Locations
  • Polymers (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (81573357)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Hydrogels: synthesis, properties, applications
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
Keywords
recurrent glioblastoma, temozolomide, thermosensitive hydrogel, PLGA-PEG-PLGA triblock copolymer, local drug delivery, polymer blending, drug release kinetics, resection cavity, biodegradable polymers, survival rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review